Fundamentals

Valuation

Metric	Q2	Q3	Δ in %
EV/EBITDA	10.69	94.35	85.24
Graham Fair Price	3.25	47.57	46.07
PEG	556.35	104.64	-15.94
Price/Book	5.39	12.34	11.71
Price/Cash Flow	-51.30	148.98	305.91
Prices/Earnings	11.62	35.59	31.88
Price/Sales	12.27	50.49	44.97
Price/FCF	-51.30	148.98	305.91
Naive Interpretation	member

01 - Valuation · Bad

Fundamentals

Profitability

Metric	Q2	Q3	Δ in %
Gross Profit Margin	2.52	0.70	0.68
Operating Margin	2.30	0.45	0.44
ROA	-2.53	0.05	0.05
ROE	0.09	0.09	-5.58
ROIC	0.07	0.07	-0.38
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q2	Q3	Δ in %
Debt QOQ	-0.10	0.04	140.44
Dividends QOQ	0.10	< 0.005	-99.78
EBIT QOQ	< 0.005	0.02	298.70
EPS QOQ	-0.02	< 0.005	-82.99
FCF QOQ	-0.56	1.30	132.52
Revenue QOQ	0.10	< 0.005	-97.32
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q2	Q3	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	7.41	6.34	-14.38
Days Sales Outstanding (DSO)	62.15	64.06	3.07
Inventory Turnover	12.15	14.19	16.79
Debt/Capitalization	0.27	0.24	-11.32
Quick Ratio	1.02	1.05	2.29
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q2	Q3	Δ in %
Book Value	32.06	34.07	6.26
Cash	10.90	10.77	-1.18
Capex	-1.31	-1.47	-12.52
Free Cash Flow	1.23	2.82	129.96
Revenue	8.34	8.32	-0.25
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q2	Q3	Δ in %
Current Ratio	1.22	1.24	1.95
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	2.12	1.79	-15.65
Naive Interpretation	Member

06 - Financial Health · Weak

Rating